De novo lipogenesis represents a therapeutic target in Kras mutant NSCLC

ABSTRACT: De novo lipogenesis represents a therapeutic target in Kras mutant NSCLC

PROVIDER: PRJNA453778 | ENA |

REPOSITORIES: ENA